Infectious Disease September 1, 2021 Senhwa secures DMC approval to advance Phase II trial of Silmitasertib By PBR Staff Writer Claimed to have high clinical potential to treat Covid-19, Silmitasertib acts on the protein kinase CK2 pathway. As a CK2-inhibitor, it is believed to hinder the active viral
RegulationApprovals August 27, 2021 Japan approves AstraZeneca’s Forxiga for chronic kidney disease By PBR Staff Writer Japan has approved AstraZeneca’s Forxiga (dapagliflozin) to treat chronic kidney disease (CKD) in adults with and without type-2 diabetes (T2D). The Japanese Ministry of Health, Labour and Welfare
Infectious Disease August 9, 2021 India approves J&J’s single-dose Covid-19 vaccine for emergency use By PBR Staff Writer This approval expands the total count of Covid-19 vaccines authorised in the country to five. Last week, J&J submitted an application seeking Emergency Use Authorization (EUA) for its
Infectious Disease August 6, 2021 Akston commences dosing in Phase II trial of Covid-19 vaccine By PBR Staff Writer This vaccine candidate is based on the company’s Fc fusion protein platform. It stimulates a Th1/Th2 mixed immune response against the receptor-binding domain (RBD) of the SARS-CoV-2 spike
Production & SalesManufacturing February 25, 2021 Moderna to boost global Covid-19 vaccine manufacturing capacity By PBR Staff Writer Moderna has announced plans to increase its global manufacturing capacity for Covid-19 vaccine by making additional capital investments. The investments will be made at the company’s owned and
Drug DiscoveryResearch & Development February 24, 2021 UCB expands partnership with Microsoft to speed up drug development By PBR Staff Writer Belgium-based biopharmaceutical firm UCB has expanded its collaboration with technology company Microsoft to accelerate discovery and development of drugs for people living with severe diseases in immunology and
Clinical Trials February 18, 2021 GlaxoSmithKline and Vir Biotechnology to expand Covid-19 partnership By PBR Staff Writer GlaxoSmithKline has signed an agreement with Vir Biotechnology to expand their Covid-19 collaboration to advance new therapeutics for influenza and other respiratory viruses. The company stated that the
Regulation February 17, 2021 Novartis secures expanded FDA indication label for Entresto By PBR Staff Writer Swiss pharmaceutical company Novartis has secured the expanded US Food and Drug Administration (FDA) indication for Entresto, a Novartis therapy to treat patients diagnosed with guideline-defined heart failure.